WOOTON PHARMACY LIMITEDActive

Company number SC615846Private limited companyIncorporated 2018

Key figures

£144,390-6.4%
Net assets 2024/25
+20.6%
Average annual growth 2020/21–2024/25
050 k100 k150 k200 k2020/212021/222022/232023/242024/25

Like most small UK companies, WOOTON PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand184,230246,397150,254222,044124,981
Total assets1,220,4221,199,6671,091,2431,077,030934,490
Total liabilities1,152,1511,083,022951,587922,762790,100
Net assets / total equity68,271116,645139,656154,268144,390
Average number of employees888913

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: WOOTON PHARMACY LIMITED

Company

WOOTON PHARMACY LIMITED is a private limited company registered with Companies House under company number SC615846. It was incorporated on 11 Dec 2018. Its status is active. The registered office is in Edinburgh (EH15). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £144,390, down 6.4% on the previous year. Cash at bank and in hand was £124,981. Total assets were £934,490 and total liabilities £790,100. The company had an average of 13 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 10 Dec 2026.